@author-1788515151757110
Beyond its homegrown efficiency advantages, China's biotech sector must also seize the opportunities presented by global collaborative clinical development in the years ahead — leveraging strengths across different regions worldwide to maximize biotech value creation.
Staying with you through the milestone moments of Qiming Venture Partners' portfolio companies
The list aims to identify outstanding companies in China's tech sector that have captured capital market attention while earning recognition from customers and the market — high-tech, high-growth ventures with strong teams, solid reputations, and cross-cycle resilience. It also seeks to honor the best CEOs and best young CEOs who possess international vision, industry insight, and leadership capabilities to steer their enterprises into a new era.
Leveraging WeRide's advanced autonomous driving technology and extensive operational experience, combined with Uber's powerful global mobility platform, the two companies will have the capability and potential to deliver quality services to millions of users worldwide.
Since its founding, Qiming Venture Partners has focused on investing in exceptional early- and growth-stage companies driven by technology and innovation.
Celebrating milestone moments with Qiming Venture Partners' portfolio companies
From application to final approval, WeRide and beti took just three months — a record for autonomous driving companies obtaining permits in France. It also means WeRide has met the highest standards in Europe for technical safety validation and operational program design.
The awards aim to establish benchmark investment institutions and enterprises with annual bellwether significance for China's pharmaceutical industry.
AI will bring enormous benefits to humanity, and it will also represent the greatest investment opportunity over the next decade.
Tashi Zhihang is the only company in the industry that simultaneously possesses Embodied Artificial Intelligence large model capabilities, in-house robotics R&D capabilities, and mass production capacity for integrated hardware-software products.
